報價延遲最少15分鐘:2026/04/29 02:19 EDT
常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
1.04 
|
|
|
| 價值評估 |
|
盈利(現時/預測)
-0.26/--
|
|
企業價值
22.52M
|
| 資產負債 |
|
每股賬面淨值
-0.06
|
| 現金流量 |
|
現金流量率
--
|
| 損益表 |
|
收益
52.68M
|
|
每股收益
3.26
|
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比較之報價最少15分鐘延遲 (夜盤時段除外)
|
業務概覽
|
|||
| IRIDEX Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures used to treat sight-threatening eye conditions, including glaucoma and retinal diseases. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim. |
